Design Therapeutics (DSGN) vs Helus Pharma (HELP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Design Therapeutics (DSGN) has outperformed Helus Pharma (HELP) over the past year, gaining 80.1% versus a gain of 73.1%. Over five years, DSGN leads with a -18.0% price change compared with -86.0% for HELP. Helus Pharma is the larger company by market cap ($767.9 million vs $731.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DSGN | HELP |
|---|---|---|
| Share price | $11.69 | $10.51 |
| Market cap | $731.58M | $767.86M |
| 1-day change | -2.34% | -2.32% |
| YTD return | +24.63% | +28.48% |
| 1-year return | +80.12% | +73.15% |
| 5-year return | -17.96% | -85.96% |
| EPS (TTM) | $-1.18 | $-4.15 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.25 | $15.15 |
| 52-week low | $5.28 | $3.76 |
| Distance from 52-week high | -32.23% | -30.63% |
| Average volume | 614.39K | 1.79M |
| Shares outstanding | 62.58M | 73.06M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
DSGN vs HELP FAQ
Which is bigger, Design Therapeutics or Helus Pharma?
Helus Pharma (HELP) is larger, with a market capitalization of $767.86M compared with $731.58M for Design Therapeutics (DSGN).
Which stock has performed better over the past year, DSGN or HELP?
DSGN returned +80.12% over the past 12 months, compared with +73.15% for HELP (price return, excluding dividends). Past performance does not predict future results.
Are Design Therapeutics and Helus Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.